The Lung Group offers its members access to information regarding current and emerging therapeutic strategies for the treatment of lung cancer and malignant pleural mesothelioma, as well as new diagnostics and basic science research.
Strong links have been forged with The Thoracic Society of Australia & New Zealand (TSANZ) and the Australasian Lung Trials Group (ALTG), and the Lung Cancer Group sees itself as playing a pivotal role in advancing knowledge about the most common fatal malignancy in Australian society.
Chair: Dr Nick Pavlakis
Join COSA now
Contact COSA for more information about this group.
Those with an interest in the treatment of lung cancer and malignant pleural mesothelioma are welcome to join the Lung Group. COSA membership comes with a range of member benefits.
To become a member of this group select the Lung membership box on the COSA joining form. Current members can join this group by selecting the Lung membership box in update profile in the members’ area.